Andrea Ghirardi, MBA

Andrea Ghirardi is an international CEO, investor, and thought leader at the intersection of longevity, technology, and applied science. He currently serves as CEO EMEA and President of Prolon (L-Nutra), a pioneering nutri-tech company redefining healthcare through advanced nutritional technologies and the “Food as Medicine” paradigm.

With over 15 years of experience across Europe and the United States, Andrea has built and scaled science-driven businesses in complex, regulated environments, consistently delivering strong revenue growth and operational transformation. Under his leadership, the European business of L-Nutra has undergone a significant expansion, combining clinical research, digital platforms, and AI-enabled systems into integrated, scalable models.

His work focuses on translating scientific innovation into real-world impact — bridging biology, data, and commercial execution to create new categories in health and longevity. He is particularly recognized for his ability to design and scale hybrid models that integrate consumer engagement, clinical validation, and long-term value creation.

Beyond his executive role, Andrea is an active investor, chairman, and board member in emerging healthcare, tech and longevity ventures, supporting the next generation of companies shaping the future of human health.

A frequent speaker at international forums, he contributes strategic perspectives on the convergence of AI, nutrition, and personalized medicine, advocating for a shift from reactive healthcare to proactive, data-driven longevity systems. He has been recognized among Forbes Italy's Top 100 CEOs.

Andrea's leadership philosophy is grounded in a simple principle: combining bold vision with disciplined execution to create sustainable impact at scale.